HealthEquity (NASDAQ:HQY) Upgraded to “Buy” at Wall Street Zen

HealthEquity (NASDAQ:HQY) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Monday.

A number of other brokerages also recently issued reports on HQY. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $120.00 price target on shares of HealthEquity in a report on Friday, December 5th. Barclays assumed coverage on HealthEquity in a research note on Monday, December 8th. They set an “overweight” rating and a $118.00 target price on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a report on Thursday, December 4th. Finally, BTIG Research restated a “buy” rating and issued a $130.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $119.60.

HealthEquity Stock Down 1.8%

Shares of NASDAQ HQY opened at $85.37 on Monday. The company has a market cap of $7.29 billion, a price-to-earnings ratio of 39.16, a PEG ratio of 1.23 and a beta of 0.20. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm’s fifty day moving average is $96.16 and its 200 day moving average is $94.49. HealthEquity has a 52 week low of $74.07 and a 52 week high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter last year, the firm earned $0.78 EPS. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Buying and Selling

In other news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 13,959 shares of company stock worth $1,344,957. Insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Large investors have recently bought and sold shares of the business. Farther Finance Advisors LLC raised its holdings in shares of HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the last quarter. True Wealth Design LLC increased its holdings in HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after acquiring an additional 317 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of HealthEquity during the 2nd quarter valued at $33,000. Cullen Frost Bankers Inc. boosted its stake in shares of HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares during the period. Finally, AlphaQuest LLC grew its holdings in HealthEquity by 52.2% during the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock valued at $59,000 after buying an additional 214 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.